BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31496210)

  • 1. IgA nephropathy and renal cell carcinoma: molecular genetic analysis.
    Li HN; Chen H; Yang XX; Xu YY; Cao Y; Geng JS; Jin XM; Meng HX
    J Biol Regul Homeost Agents; 2019 September-October,; 33(5):1571-1575. PubMed ID: 31496210
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal cell carcinoma in association with IgA nephropathy in the elderly.
    Mimura I; Tojo A; Kinugasa S; Uozaki H; Fujita T
    Am J Med Sci; 2009 Nov; 338(5):431-2. PubMed ID: 19773639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgA mesangial nephropathy associated with renal cell carcinoma.
    Sessa A; Volpi A; Tetta C; Meroni M; Torri Tarelli L; Battini G; Camussi G; Conte F; Ferrario G; Giordano F
    Appl Pathol; 1989; 7(3):188-91. PubMed ID: 2669863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgA glomerulonephritis in a patient with renal cell carcinoma.
    Tanaka K; Kanzaki H; Taguchi T
    Nihon Jinzo Gakkai Shi; 1991 Jan; 33(1):87-90. PubMed ID: 2038137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Non-Hodgkin lymphoma, IgA nephropathy and renal cell carcinoma].
    Ceres F; Rivera F; Yagüe JL; Blanco J; García-Rojo M; Sánchez de la Nieta MD; Alcázar R; de la Torre M
    Nefrologia; 2003; 23(6):554-7. PubMed ID: 15002792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid Biopsy: A New Avenue for the Diagnosis of Kidney Disease: Diabetic Kidney Disease, Renal Cancer, and IgA Nephropathy.
    Dybiec J; Frąk W; Kućmierz J; Tokarek J; Wojtasińska A; Młynarska E; Rysz J; Franczyk B
    Genes (Basel); 2024 Jan; 15(1):. PubMed ID: 38254967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of nuclear factor-kappaB in IgA nephropathy using Southwestern histochemistry.
    Ashizawa M; Miyazaki M; Abe K; Furusu A; Isomoto H; Harada T; Ozono Y; Sakai H; Koji T; Kohno S
    Am J Kidney Dis; 2003 Jul; 42(1):76-86. PubMed ID: 12830459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Siblings with IgA nephropathy and diffuse proliferative glomerulonephritis (PGN) associated with identical HL-A antigens.
    Miura M; Tomino Y; Yagame M; Suga T; Endoh M; Nomoto Y; Sakai H
    Tokai J Exp Clin Med; 1986 Nov; 11(5):323-7. PubMed ID: 3313816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Enucleation performed to treat renal cell carcinoma associated with chronic nephritis: a case report].
    Oya M; Hata M; Yoshioka K; Hayashi S; Tazaki H; Okada H; Konishi K
    Hinyokika Kiyo; 1991 Sep; 37(9):1041-4. PubMed ID: 1785412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No association between a genetic variant of the p22(phox) component of NAD(P)H oxidase and the incidence and progression of IgA nephropathy.
    Wolf G; Panzer U; Harendza S; Wenzel U; Stahl RA
    Nephrol Dial Transplant; 2002 Aug; 17(8):1509-12. PubMed ID: 12147803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal cell carcinoma presenting with acute renal failure and IgA glomerulonephritis.
    Abu-Romeh SH; al-Adnani MS; Asfar S
    Nephron; 1988; 50(2):169-70. PubMed ID: 3221953
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of a T-cell receptor constant alpha chain gene polymorphism with progression of IgA nephropathy in Japanese patients.
    Deenitchina SS; Shinozaki M; Hirano T; Ando T; Hirakata H; Kiyohara Y; Katafuchi R; Fujishima M
    Am J Kidney Dis; 1999 Aug; 34(2):279-88. PubMed ID: 10430975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphism of C3 and Bf in IgA nephropathy.
    Rambausek M; van den Wall Bake AW; Schumacher-Ach R; Spitzenberg R; Rother U; van Es LA; Ritz E
    Nephrol Dial Transplant; 1987; 2(4):208-11. PubMed ID: 3118258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of IgA nephropathy.
    Wada J; Sugiyama H; Makino H
    Semin Nephrol; 2003 Nov; 23(6):556-63. PubMed ID: 14631563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathogenetic aspects and gene polymorphisms of IgA nephropathy.
    Maixnerová D; Merta M; Reiterová J; Stekrová J; Rysavá R; Obeidová H; Tesar V
    Prague Med Rep; 2006; 107(2):171-88. PubMed ID: 17066738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controversies concerning the importance of genetic polymorphism in IgA nephropathy.
    Frimat L; Kessler M
    Nephrol Dial Transplant; 2002 Apr; 17(4):542-5. PubMed ID: 11917041
    [No Abstract]   [Full Text] [Related]  

  • 17. Recurrent IgA nephropathy in living-related donor transplantation: recurrence or transmission of familial disease?
    Brensilver JM; Mallat S; Scholes J; McCabe R
    Am J Kidney Dis; 1988 Aug; 12(2):147-51. PubMed ID: 3041801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology and treatment of IgA nephropathy in children.
    Yoshikawa N; Tanaka R; Iijima K
    Pediatr Nephrol; 2001 May; 16(5):446-57. PubMed ID: 11405121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Heterogeneity in Familial IgA Nephropathy.
    Fennelly NK; Kennedy C; Jenkinson AC; Connaughton DM; Stapleton C; Dorman AM; Doyle B; Conlon PJ
    Nephron; 2018; 139(1):63-69. PubMed ID: 29402819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial IgA nephropathy.
    Scolari F
    J Nephrol; 1999; 12(4):213-9. PubMed ID: 10493564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.